UNSPSC 51373446: Codeine/ipecac/potassium guaiacolsulfonate/promethazine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373446 Codeine/ipecac/potassium guaiacolsulfonate/promethazine (Commodity) reflects a mismatch between its nominal pharmaceutical scope and the actual work state and local governments are buying under this code. The recent opportunities posted under this code involve parenteral nutrition solutions, intravenous products, naloxone, and drug deactivation systems — not the specific combination pharmaceutical products the code name specifies. State and local procurement offices appear to be using this code as a catch-all for injectable pharmaceuticals and related medical products supplied to correctional facilities and public health agencies, rather than limiting it to the precise drug formulations the code ostensibly describes.

The issuing bodies soliciting under this code include the Washington State Department of Corrections and Seminole County, Florida, with the Washington opportunity representing the more substantial recent activity. The Washington RFQ (RFQQK13020) due October 7, 2026 targets parenteral nutrition and IV solutions for eight correctional facilities across three regions, with DOC anticipating multiple contractor awards per region and a contract term running through June 30, 2030; the solicitation emphasizes small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation under state preference programs. The Seminole County IFB (IFB60459723LAS) sought annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, though the posted due date appears outdated relative to the posting date. Geographic activity concentrates in Washington and Florida, with no clear indication of activity in other states in the recent record.